Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tianxing, Guo"'
Autor:
Tianxing Guo, Zhaofeng Wang, Song Wang, Yaru Zhang, Jiaohui Pang, Yajun Ying, Qiuxiang Ou, Dong Shen, Gang Li
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 10, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/b71ebea77f1e433399f05206cd1c7358
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 17 (2023)
Background: Non–small cell lung cancer (NSCLC) with TP53 mutations has a worse prognosis. It was generally more resistant to chemotherapy and radiation. Our aim was to investigate the correlation between the TP53 co-mutated gene and clinical featur
Externí odkaz:
https://doaj.org/article/9a8ff781460247b782662badfbe384ec
Autor:
Yiyong Chen, Juan Zhang, Jing Chen, Zijie Yang, Yun Ding, Wenshu Chen, Tianxing Guo, Lilan Zhao, Xiaojie Pan
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionThe impact of rib invasion on the non-small cell lung cancer (NSCLC) T classifications remains unclear. Our study aims to verify the impact of rib invasion on survival in patients with NSCLC through multicenter data from the Surveillance,
Externí odkaz:
https://doaj.org/article/079e36ca73cf4e6c96c7699df4fbed4f
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1278-1287 (2021)
Background Programmed cell death protein 1 (PD-1) inhibitors are the first-line treatment for advanced non-small-cell lung cancer (NSCLC) patients. However, their efficacy in metastatic NSCLC patients remains controversial. Aim of the study The aim o
Externí odkaz:
https://doaj.org/article/9ca03693ba464261906a620705690b6c
Autor:
Wenshu Chen, Guanying Zheng, Jianyuan Huang, Lihuan Zhu, Wujin Li, Tianxing Guo, Yangyun Huang, Xiaojie Pan
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Metastasis and disease refractoriness remain as major challenges for non-small cell lung cancer (NSCLC) treatment and understanding the underlying molecular mechanisms is of scientific and clinical value. Therefore, in this study,
Externí odkaz:
https://doaj.org/article/903c20dba4e14e2487a81d601202cecf
Autor:
Wenbao Lin, Jinlan Lin, Yangyun Huang, Lihuang Zhu, Wujin Li, Lilan Zhao, Xiaojie Pan, Tianxing Guo
Publikováno v:
Journal of Gastrointestinal Oncology. 13:2758-2768
Background Pembrolizumab has been approved by the Food and Drug Administration (FDA) for the first-line treatment of locally advanced or metastatic esophageal cancer. This study investigated the efficacy and safety of pembrolizumab combined with pacl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1989952c2304e65b52f4e9d3d612a1
https://doi.org/10.21037/jgo-22-1196
https://doi.org/10.21037/jgo-22-1196
Publikováno v:
Bioengineered. 13:4991-5004
Circular RNAs play important roles in cancer biology. In this research, we explored the underlying function and mechanism of cirMMD_007 in lung adenocarcinoma (LC). Clinical lung adenocarcinoma samples were obtained from surgery. Bioinformatic databa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b09cf3ec3970388256ab92c566fd12
https://doi.org/10.1080/21655979.2022.2037956
https://doi.org/10.1080/21655979.2022.2037956
Autor:
Tianxing Guo, Zhenlong Zhang, Lihuan Zhu, Wenshu Chen, Yun Ding, Wujin Li, Yangyun Huang, Jianyuan Huang, Xiaojie Pan
Publikováno v:
Cancer Biology & Therapy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Up until now, cancer refractoriness and distal organ metastatic disease remain as major obstacles for oncologists to achieve satisfactory therapeutic effects for lung adenocarcinoma patients. Previous studies indicated that TRIM55, which participates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f9df45126b911f90e0aac20f2f21f6
http://europepmc.org/articles/PMC8812808
http://europepmc.org/articles/PMC8812808
Can a holistic view facilitate the development of intelligent traditional Chinese medicine? A survey
Autor:
Guihua Tian, Kun Qian, Xinyi Li, Mengkai Sun, Hao Jiang, Wanyong Qiu, Xiaoming Xie, Zhonghao Zhao, Liangqing Huang, Siyan Luo, Tianxing Guo, Ran Cai, Zhihua Wang, Björn W. Schuller
Intelligent traditional Chinese medicine (ITCM) is an emerging interdisciplinary subject. It aims to efficiently and precisely promote the prevention and treatment of diseases and health management in Chinese medicine clinical practice via the combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f3ef1b24d4f440f145feb27b7795466
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/104089
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/104089
Publikováno v:
Diseases of the Esophagus. 35
The standard esophageal replacement after esophagectomy for cancer treatment is a gastric conduit. However, when the stomach is not available, a jejunal interposition can be performed under such circumstances. The purpose of this study was to review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::477cbc8ba1d96859150356ad6676a84b
https://doi.org/10.1093/dote/doac051.199
https://doi.org/10.1093/dote/doac051.199